Safe Orthopaedics is selling at 0.0661 as of the 3rd of December 2024; that is 10.68% down since the beginning of the trading day. The stock's last reported lowest price was 0.066. Safe Orthopaedics has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Safe Orthopaedics has reported 3000 for 1 split on 16th of September 2024. Equity ratings for Safe Orthopaedics SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of September 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company was founded in 2010 and is headquartered in ragny-sur-Oise, France. The company has 79.68 M outstanding shares. More on Safe Orthopaedics SA
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Safe Orthopaedics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Safe Orthopaedics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Safe Orthopaedics SA (ALSAF) is traded on Euronext Paris in France and employs 136 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 147.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Safe Orthopaedics's market, we take the total number of its shares issued and multiply it by Safe Orthopaedics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Safe Orthopaedics operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 79.68 M outstanding shares.
Safe Orthopaedics SA has accumulated about 913 K in cash with (6.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Safe Orthopaedics Probability Of Bankruptcy
Safe Orthopaedics Risk Profiles
Although Safe Orthopaedics' alpha and beta are two of the key measurements used to evaluate Safe Orthopaedics' performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Safe Orthopaedics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Theme Ratings Now
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Elected by the shareholders, the Safe Orthopaedics' board of directors comprises two types of representatives: Safe Orthopaedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Safe. The board's role is to monitor Safe Orthopaedics' management team and ensure that shareholders' interests are well served. Safe Orthopaedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Safe Orthopaedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
When running Safe Orthopaedics' price analysis, check to measure Safe Orthopaedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safe Orthopaedics is operating at the current time. Most of Safe Orthopaedics' value examination focuses on studying past and present price action to predict the probability of Safe Orthopaedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safe Orthopaedics' price. Additionally, you may evaluate how the addition of Safe Orthopaedics to your portfolios can decrease your overall portfolio volatility.